Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis.

Inflammopharmacology · 2023 · PMC9707187 · PMID 36445552

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantlyno p-value reported

Besides, GM-CSF antibodies treatment was almost significantly reduced the rate of pulmonary AEs in COVID-19 patients.

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.